 |
인쇄하기
취소
|
LG life Science launches the first diabetes treatment combination drug in Korea
Published: 2013-11-27 06:56:00
Updated: 2013-11-27 06:56:00
471 won / tab. Through Insurance price negotiation.. one tab daily, convenience improving of 1 tab daily
(Medipana)
LG Life Science finished the final price negotiation of diabetes treatment combination drug, ‘Gemimet,’ developed by its own technology and launched in local market.
LG Life Science met the insurance reimbursement standard followed by general rule of diabetes treatment dr...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.